newsfilter
← Latest News
Business Wire·

ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation

UK-based study identifies key patient-centered factors influencing treatment preferences in high-risk NMIBC ImmunityBio, Inc. ((